Cargando…

PD1 is highly expressed in diffuse large B-cell lymphoma with hepatitis B virus infection

OBJECTIVE: The purpose of this study was to determine the association between PD1 expression and the clinical prognosis of diffuse large B-cell lymphoma (DLBCL) co-occurring with hepatitis B virus (HBV) infection. METHODS: A total of 165 patients presented with newly diagnosed and untreated DLBCL at...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Zhihe, Li, Siyun, Liu, Yingmin, Guo, Wei, Bai, Ou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491214/ https://www.ncbi.nlm.nih.gov/pubmed/28662185 http://dx.doi.org/10.1371/journal.pone.0180390

Ejemplares similares

MYC Gene Rearrangements Are Closely Associated with Poor Survival of Diffuse Large B Cell Lymphoma with Hepatitis B Virus Infection
por: Liu, Zhihe, et al.
Publicado: (2017)

Capable Infection of Hepatitis B Virus in Diffuse Large B-cell Lymphoma
por: Wang, Yanchun, et al.
Publicado: (2018)

Clinical Analysis and Prognostic Significance of Hepatitis B Virus Infections with Diffuse Large B-Cell Lymphoma
por: Kang, Xindan, et al.
Publicado: (2020)

Clinical and prognostic analysis of hepatitis B virus infection in diffuse large B-cell lymphoma
por: Wang, Feng, et al.
Publicado: (2008)

Effect of infection with hepatitis B virus on the survival outcome of diffuse large B-cell lymphoma in the prophylactic antiviral era
por: Nuersulitan, Reyizha, et al.
Publicado: (2022)

Concurrent and reactivation of hepatitis B virus infection in diffuse large B-cell lymphoma: risk factors and survival outcome
por: Guo, Ya-fei, et al.
Publicado: (2018)

Primary hepatic diffuse large B cell lymphoma: A case report: Primary hepatic diffuse large B cell lymphoma
por: Ma, Yuan-Ji, et al.
Publicado: (2011)

Expression and Prognostic Significance of PD-L2 in Diffuse Large B-Cell Lymphoma
por: Gu, Qianhui, et al.
Publicado: (2021)

Poor Prognosis of Diffuse Large B-Cell Lymphoma with Hepatitis C Infection
por: Tsai, Yu-Fen, et al.
Publicado: (2021)

Expression of PD-L1 and YWHAZ in Patients with Diffuse Large B Cell Lymphoma: A Possible Association with the Prognosis of Lymphoma
por: Yan, Shufang, et al.
Publicado: (2022)

Clinical analysis and prognostic significance of hepatitis B virus infections for diffuse large B-cell lymphoma with or without rituximab therapy
por: XIE, WANZHUO, et al.
Publicado: (2013)

PD-1 Blockade Can Restore Functions of T-Cells in Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma In Vitro
por: Quan, Lina, et al.
Publicado: (2015)

P1292: MOLECULAR CHARACTERIZATION OF DIFFUSE LARGE B-CELL LYMPHOMA ASSOCIATED TO HEPATITIS C VIRUS INFECTION
por: Sciarra, R., et al.
Publicado: (2022)

A Hepatitis B Virus Reactivation Case Potentially Triggered by the Onset of Diffuse Large B Cell Lymphoma
por: Sato, Kentaro, et al.
Publicado: (2022)

Primary breast diffuse large B cell lymphoma
por: Guo, Mengni, et al.
Publicado: (2022)

The expression and clinical relevance of PD-1, PD-L1, and TP63 in patients with diffuse large B-cell lymphoma
por: Fang, Xia, et al.
Publicado: (2017)

Pro-oncogenic, intra host viral quasispecies in Diffuse large B cell lymphoma patients with occult Hepatitis B Virus infection
por: Sinha, Mahua, et al.
Publicado: (2019)

High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from Italy
por: Visentini, Marcella, et al.
Publicado: (2023)

Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: risk factors and survival
por: Chen, Kai-Lin, et al.
Publicado: (2015)

LAG3 and PD1 Regulate CD8+ T Cell in Diffuse Large B-cell Lymphoma Patients
por: Liu, Ying, et al.
Publicado: (2021)

Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy
por: Guo, Wei, et al.
Publicado: (2020)

Clinical Analysis of the HBV Infection Status of 135 Patients with Diffuse Large B Cell Lymphoma Treated with R-CHOP or CHOP/CHOP-Like Chemotherapy
por: Guo, Wei, et al.
Publicado: (2015)

Hepatitis B virus-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis B surface antigen-driven origin
por: Deng, Lijuan, et al.
Publicado: (2015)

The PD-1/PD-L1 Checkpoint in Normal Germinal Centers and Diffuse Large B-Cell Lymphomas
por: Garcia-Lacarte, Marcos, et al.
Publicado: (2021)

Clinicopathologic implication of PD-L1 and phosphorylated STAT3 expression in diffuse large B cell lymphoma
por: Kwon, Hyun Jung, et al.
Publicado: (2018)

Swollen lymph nodes may not be clinical manifestations of chronic myeloid leukemia: case report and revision of literature
por: Liu, Zhihe, et al.
Publicado: (2017)

Angiomirs expression profiling in diffuse large B-Cell lymphoma
por: Borges, Natália M., et al.
Publicado: (2015)

An Unusual Presentation of Primary Hepatic Diffuse Large B-cell Lymphoma of the Liver
por: Dhingra, Rohit, et al.
Publicado: (2018)

Primary Hepatic Diffuse Large B-cell Lymphoma Mimicking Intrahepatic Cholangiocarcinoma
por: Kawakami, Hiroshi, et al.
Publicado: (2018)

Fatal Hepatocellular Carcinoma in a Patient with Occult Hepatitis B Virus Infection following the Administration of R-CHOP for Diffuse Large B-Cell Lymphoma
por: Pitini, Vincenzo, et al.
Publicado: (2012)

Chronic hepatitis B virus infection is associated with a poorer prognosis in diffuse large B-cell lymphoma: a meta-analysis and systemic review
por: Rong, Xingyu, et al.
Publicado: (2019)

Epstein–Barr Virus and the Pathogenesis of Diffuse Large B-Cell Lymphoma
por: Ross, Aisling M., et al.
Publicado: (2023)

Diagnostic Performance of PD-L1 versus PD-1 Expression in Circulating CD20 Cells in Diffuse Large B-Cell Lymphoma
por: Saber, Manal Mohamed
Publicado: (2022)

Genomic and transcriptomic characterization reveals B‐cell hyperactivation and immune evasion in hepatitis B virus‐associated diffuse large B‐cell lymphoma
por: Qin, Wei, et al.
Publicado: (2023)

PD-L1 expression in EBV-negative diffuse large B-cell lymphoma: clinicopathologic features and prognostic implications
por: Xing, Wei, et al.
Publicado: (2016)

Expression of Tryptophan Metabolism Enzymes in Patients with Diffuse Large B‐cell Lymphoma and NK/T‐cell Lymphoma
por: Guo, Dan, et al.
Publicado: (2023)

Antiviral therapy in hepatitis C-infected patients prevents relapse of diffuse large B cell lymphoma
por: Pellicelli, Adriano, et al.
Publicado: (2018)

Ovary involvement of diffuse large B-cell lymphoma
por: Hu, Rong, et al.
Publicado: (2012)

Comparison of PD‐L1 detection assays and corresponding significance in evaluation of diffuse large B‐cell lymphoma
por: Huang, Sixia, et al.
Publicado: (2019)

Simultaneous Presence of Follicular Lymphoma, Diffuse Large B-cell Lymphoma, and Hodgkin-like Lymphoma
por: Papoudou-Bai, Alexandra, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_au8qsgc3amgmmq1r6jm1qrpmca